![Jesse Neri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jesse Neri
Direttore Finanziario/CFO presso ROCKWELL MEDICAL, INC.
Patrimonio netto: 58 661 $ in data 30/06/2024
Posizioni attive di Jesse Neri
Società | Posizione | Inizio | Fine |
---|---|---|---|
ROCKWELL MEDICAL, INC. | Direttore Finanziario/CFO | 18/10/2023 | - |
Storia della carriera di Jesse Neri
Precedenti posizioni note di Jesse Neri
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZYLA LIFE SCIENCES | Corporate Officer/Principal | 01/06/2015 | - |
Formazione di Jesse Neri
Villanova University | Undergraduate Degree |
Drexel University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ROCKWELL MEDICAL, INC. | Health Technology |
Aziende private | 1 |
---|---|
Zyla Life Sciences LLC
![]() Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Borsa valori
- Insiders
- Jesse Neri
- Esperienza